Skip to content

Drug interactions

Lomustine + Meningococcal a c y and w-135 polysaccharide vaccine combined

Severity: Moderate

Lomustine and Meningococcal a c y and w-135 polysaccharide vaccine combined: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomustine immunosuppression may reduce the antibody response to meningococcal polysaccharide vaccine, leaving patients less protected against invasive disease.

What this interaction means in plain words

Lomustine and Meningococcal a c y and w-135 polysaccharide vaccine combined can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Cytotoxic suppression of lymphocytes and bone marrow reduces vaccine-induced immune response.

What to do

Vaccinate at least 2 weeks before lomustine when possible; otherwise revaccinate about 3 months after therapy ends.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomustine and Meningococcal a c y and w-135 polysaccharide vaccine combined, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomustine with Meningococcal a c y and w-135 polysaccharide vaccine combined?

MediHelp rates the interaction as moderate. Lomustine and Meningococcal a c y and w-135 polysaccharide vaccine combined can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lomustine immunosuppression may reduce the antibody response to meningococcal polysaccharide vaccine, leaving patients less protected against invasive disease.

How serious is the interaction between Lomustine and Meningococcal a c y and w-135 polysaccharide vaccine combined?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate at least 2 weeks before lomustine when possible; otherwise revaccinate about 3 months after therapy ends.

What other medicines interact with Lomustine?

MediHelp also lists interactions of Lomustine with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Lomustine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in